In this interview with BioSpace, AGC Biologics' Anders Cai Holm Hansen, Principal Scientist & Technical Specialist, discusses the strategies behind a flexible single-use scale-out manufacturing approach rather than the traditional scale-up method. By utilizing AGC Biologics' modular bioreactor system, Anders shares how developers can avoid major pitfalls and accelerate their path to market without having to make the expensive decision to move product to large-scale stainless steel bioreactors.
Listen to this podcast and get an insider's look at why choosing an agile path to commercialization means stability even when demand and external factors change your project's needs.
Click below to listen:
